US EditionPublished • loading... • Updated
Zepp Health Corporation Reports Fourth Quarter and Full Year 2025 Unaudited Financial Results
FinVolution's 2025 net profit rose 6.6% to RMB2.5 billion, driven by 41.4% international transaction volume growth despite tighter underwriting in China.
- FinVolution announced Q4 and FY 2025 results, reporting RMB3,023.9 million net revenue and RMB415.5 million net profit on March 16, 2026.
- Amid China regulatory shifts, management said tighter underwriting reduced Q4 revenue impact as China transaction volume fell to RMB38.7 billion.
- Across overseas markets, international transaction volume reached RMB4.1 billion, with 3.8 million unique international borrowers and 31.4% of Q4 net revenue, offsetting China weakness.
- Looking to 2026, FinVolution set full-year revenue guidance at RMB11.5 billion to RMB12.9 billion amid China uncertainty, with a US$107.2 million share repurchase program and a US$0.306 dividend per ADS.
- At the same time, the group recorded an impairment of RMB50.7 million in goodwill and intangible assets, according to management.
Insights by Ground AI
85 Articles
85 Articles
Coverage Details
Total News Sources85
Leaning Left12Leaning Right5Center32Last UpdatedBias Distribution65% Center
Bias Distribution
- 65% of the sources are Center
65% Center
L 25%
C 65%
Factuality
To view factuality data please Upgrade to Premium
